Lupin receives US FDA approval for Risperidone long-acting Injectable
Lupin, a global pharma company has received the United States Food and Drug Administration (US FDA) approval for its Abbreviated…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Lupin
NATCO Pharma launches generic Bosentan tablets for oral suspension in the United States
NATCO partners with Lupin for Bosentan tablets, gains 180-day exclusivity for pulmonary arterial hypertension treatment in…
Lupin gains US FDA approvals for Liraglutide and Glucagon Injectable Products
Both these products will be manufactured at Lupin’s Injectable facility at Nagpur, India
Lupin achieves GMP Certification from TGA Australia for dabhasa API facility
LMS offers pharma CDMO services and manufactures APIs
Lupin launches Loteprednol Etabonate Ophthalmic Suspension, 0.5 per cent in the US
Loteprednol Etabonate Ophthalmic Suspension (RLD Lotemax) had estimated annual sales of $ 55 million in the US (IQVIA MAT May…
Lupin signs license and supply agreement with Zentiva for commercialising Certolizumab
Lupin and a pan-European pharmaceutical company, Zentiva have entered into a license and supply agreement for commercialisation of…
Lupin launches Ipratropium Bromide Nasal Solution (Nasal Spray), 0.03 per cent and 0.06 per cent in…
The medication is indicated for the symptomatic relief of rhinorrhea associated with allergic and nonallergic perennial rhinitis…
Lupin gains USFDA approval for Loteprednol Etabonate Ophthalmic Gel
Being the exclusive first-to-file, Lupin is eligible for 180-day generic exclusivity
Lupin receives approval from US FDA for Prucalopride Tablets
The approved tablets are bioequivalent to Takeda’s Motegrity and will be manufactured at Lupin’s Goa facility
Lupin announces presentation of phase 1 data on LNP7457 (PRMT5 inhibitor) at the ASCO – Annual…
Current data from Lupin indicates that LNP7457 is unique within its field and appears to be safe and well-tolerated as a…